Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
Article
Article Title | Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age |
---|---|
ERA Journal ID | 16169 |
Article Category | Article |
Authors | Kondalsamy-Chennakesavan, Srinivas (Author), Hackethal, Andreas (Author), Bowtell, David (Author) and Obermair, Andreas (Author) |
Journal Title | Gynecologic Oncology |
Journal Citation | 129 (3), pp. 467-471 |
Number of Pages | 5 |
Year | 2013 |
Place of Publication | Maryland Heights, MO. United States |
ISSN | 0090-8258 |
1095-6859 | |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.ygyno.2013.03.001 |
Abstract | Objective: Evaluating the presence of possible malignant disease in women with ovarian masses relies on medical imaging and serum marker findings. This study considers the role of serum Human Epididymal Protein 4 (HE4) antigen in combination with other serum markers to more effectively estimate the risk of malignancy in patients with isolated pelvic masses. |
Keywords | adnexal mass; CA-125; CEA; HE4; ovarian cancer |
ANZSRC Field of Research 2020 | 321101. Cancer cell biology |
320602. Medical biotechnology diagnostics (incl. biosensors) | |
321102. Cancer diagnosis | |
Public Notes | © 2013 Elsevier Inc. Published version deposited in accordance with the copyright policy of the publisher. |
Byline Affiliations | Centre for Rural and Remote Area Health |
Department of Health, Queensland | |
Peter MacCallum Cancer Centre, Australia | |
Institution of Origin | University of Southern Queensland |
https://research.usq.edu.au/item/q1zy9/differentiating-stage-1-epithelial-ovarian-cancer-from-benign-ovarian-tumours-using-a-combination-of-tumour-markers-he4-ca125-and-cea-and-patient-s-age
1814
total views8
total downloads1
views this month0
downloads this month